| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hulls Chris | Director | C/O LIFE360, INC., 1900 SOUTH NORFOLK STREET, SUITE 310, SAN MATEO | /s/ Allison Chang, Attorney-in-Fact | 03 Sep 2025 | 0001932498 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIF | Common Stock | Award | $0 | +26.5K | +5.79% | $0.00 | 484K | 01 Sep 2025 | Direct | F1, F2, F3 |
| holding | LIF | Common Stock | 195K | 01 Sep 2025 | Held by the Robin Hulls 2023 Irrevocable Trust | F4 | |||||
| holding | LIF | Common Stock | 195K | 01 Sep 2025 | Held by the Rose Hulls 2023 Irrevocable Trust | F4 | |||||
| holding | LIF | Common Stock | 195K | 01 Sep 2025 | Held by the Mckenzie Hulls 2023 Irrevocable Trust | F4 | |||||
| holding | LIF | Common Stock | 1.85K | 01 Sep 2025 | Held by ICCA Labs, LLC | F5 |
| Id | Content |
|---|---|
| F1 | Represents the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/48th of the RSUs will vest monthly from September 1, 2025, subject to the Reporting Person's continuous service through each vesting date. |
| F2 | Includes 151,934 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| F3 | Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. |
| F4 | Represents shares of the Issuer's common stock underlying 585,938 CDIs, which remain subject to a lock-up agreement. |
| F5 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |